Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.250 $0.685 Friday, 10th May 2024 ADXS stock ended at $0.437. This is 21.96% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 108.00% from a day low at $0.250 to a day high of $0.520.
90 days $0.250 $1.05
52 weeks $0.250 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Jun 01, 2016 $141.60 $141.60 $141.60 $141.60 44 337
May 31, 2016 $138.90 $138.90 $138.90 $138.90 51 934
May 27, 2016 $135.60 $135.60 $135.60 $135.60 43 164
May 26, 2016 $131.10 $131.10 $131.10 $131.10 29 540
May 25, 2016 $131.25 $131.25 $131.25 $131.25 41 355
May 24, 2016 $124.50 $124.50 $124.50 $124.50 37 560
May 23, 2016 $122.40 $122.40 $122.40 $122.40 34 396
May 20, 2016 $119.10 $119.10 $119.10 $119.10 33 214
May 19, 2016 $113.10 $113.10 $113.10 $113.10 35 470
May 18, 2016 $114.45 $114.45 $114.45 $114.45 33 783
May 17, 2016 $113.40 $113.40 $113.40 $113.40 62 690
May 16, 2016 $105.15 $105.15 $105.15 $105.15 107 862
May 13, 2016 $108.90 $108.90 $108.90 $108.90 41 948
May 12, 2016 $112.20 $112.20 $112.20 $112.20 81 675
May 11, 2016 $121.95 $121.95 $121.95 $121.95 53 503
May 10, 2016 $114.75 $114.75 $114.75 $114.75 31 592
May 09, 2016 $115.50 $115.50 $115.50 $115.50 43 855
May 06, 2016 $107.55 $107.55 $107.55 $107.55 51 107
May 05, 2016 $110.85 $110.85 $110.85 $110.85 46 613
May 04, 2016 $106.05 $106.05 $106.05 $106.05 41 879
May 03, 2016 $114.45 $114.45 $114.45 $114.45 38 075
May 02, 2016 $117.00 $117.00 $117.00 $117.00 40 571
Apr 29, 2016 $116.10 $116.10 $116.10 $116.10 47 759
Apr 28, 2016 $124.65 $124.65 $124.65 $124.65 76 519
Apr 27, 2016 $120.90 $120.90 $120.90 $120.90 65 899
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT